Poorly Differentiated Prostate Adenocarcinoma

An invasive prostate adenocarcinoma characterized by the presence of malignant cells exhibiting poor differentiation.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1997-2015
01219972015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Cryoglobulinemia refers to the presence of circulating cryoglobulins in the serum which may lead to organ damage and systemic… (More)
  • figure 1
  • table 1
Is this relevant?
2014
2014
F-FDG PET/CT of a patient with inflammatory lower back pain reveals diffuse bony metastases, similar to the "superscan" found on… (More)
Is this relevant?
2013
2013
In living patients brain metastases of prostate cancer are extremely rare (1 %), generally occurring in end-stage disease when… (More)
Is this relevant?
2006
2006
An optimal immunohistochemical panel to distinguish poorly differentiated prostate (PCa) from urothelial (UCa) carcinoma was… (More)
Is this relevant?
2005
2005
We report a case of orbital metastasis from a neuroendocrine dedifferentiated prostate cancer during progression from hormone… (More)
Is this relevant?
2004
2004
Id1 and Id3 genes are required for vascularization, growth, and metastasis of xenograft tumors. In Id-deficient mice, tumor… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2002
2002
The differential diagnosis between poorly differentiated prostate adenocarcinoma (PAC) involving the bladder and high-grade… (More)
Is this relevant?
2000
2000
Prostatic small cell carcinoma is an aggressive subtype of prostate cancer that usually appears as a progression of the original… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
Is this relevant?
Highly Cited
1999
Highly Cited
1999
The ability to manipulate gene expression in specific cell types at specific times utilizing transgenic technology has allowed… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1997
1997
Human endopeptidase 24.11 (EP) occurs in greatest abundance on terminally differentiated prostate cells; thus, loss of EP could… (More)
  • figure 1
  • table 1
Is this relevant?